← Back to all signals

CC Chemours Co

Last updated: May 11, 2026

🐂

Execution Consistency

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 4/4 quarters. Q3 2024: $18M, Q2 2024: $37M, Q1 2024: $14M, Q3 2023: $79M

🐻

Execution Acceleration

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $18M vs trailing avg $43M (-58%)

🐻

Buyback vs FCF

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Negative FCF ($-1.7B), buybacks not supported by cash flow

Buyback Intensity

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Missing shares repurchased or outstanding data

🐂

Insider Buying

Are officers and directors buying stock with their own money on the open market?

4 open-market purchases by 3 insiders

  • Dignam Denise (President & CEO) bought 4,068 shares at $12.06 on 2025-08-08
  • Gumpel Damian (See Remarks) bought 7,822 shares at $9.95 on 2025-06-03
  • Gumpel Damian (See Remarks) bought 13,400 shares at $9.22 on 2025-06-02
  • HOSTETTER SHANE (Chief Financial Officer) bought 4,450 shares at $11.28 on 2025-05-19
🐂

Insider-Buyback Convergence

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Company buybacks in 4 quarters and 4 insider purchases by 3 insiders (no calendar overlap, but both independently active)

🐂

Insider Net Direction

Over the last 90 days, are insiders net buyers or net sellers on the open market?

Insiders bought $0M, sold $0M in the last 90 days (net buying)

Red Flag

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected